Where Medicine Stops, Cell Therapy Begins…
Advanced autologous PRP, PRF, and exosome therapies to improve ovarian reserve, AMH levels, and egg quality.
Advanced autologous PRP, PRF, and exosome therapies to repair thin endometrial lining, address RIF, and enhance implantation success.
Pioneered autologous intra-amniotic fibrin and platelet injection (IFPI) fetal therapy to support natural membrane healing in previable PROM.
Advanced autologous PRP, PRF, and exosome therapies to optimize embryo implantation, treat RIF, and prevent recurrent pregnancy loss.